Alan L. Crane, Director, 10% Owner at Pandion Therapeutics, Inc. (PAND), bought 2,834,003 shares at $18.00 ($902K) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,783,892 | $0 | 0.0% |
| 2 | $18.00 | 1,248 | $22K | 2.5% |
| 3 | $18.00 | 14,000 | $252K | 27.9% |
| 4 | $18.00 | 34,863 | $628K | 69.6% |
| Total | $0.32 avg | 2,834,003 | $902K | 100% |
| Filing → |
| MNTA | SELL | 2007-01-12 | $873K | — | Filing → |
| MNTA | SELL | 2006-12-20 | $1.0M | — | Filing → |
| MNTA | SELL | 2006-12-12 | $880K | — | Filing → |